491 related articles for article (PubMed ID: 16917507)
1. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
2. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
3. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.
Kitabayashi I; Yokoyama A; Shimizu K; Ohki M
EMBO J; 1998 Jun; 17(11):2994-3004. PubMed ID: 9606182
[TBL] [Abstract][Full Text] [Related]
4. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.
Tomita A; Towatari M; Tsuzuki S; Hayakawa F; Kosugi H; Tamai K; Miyazaki T; Kinoshita T; Saito H
Oncogene; 2000 Jan; 19(3):444-51. PubMed ID: 10656693
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
6. Histone modifications in kainate-induced status epilepticus.
Sng JC; Taniura H; Yoneda Y
Eur J Neurosci; 2006 Mar; 23(5):1269-82. PubMed ID: 16553789
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.
Oelgeschläger M; Janknecht R; Krieg J; Schreek S; Lüscher B
EMBO J; 1996 Jun; 15(11):2771-80. PubMed ID: 8654374
[TBL] [Abstract][Full Text] [Related]
8. HATs off to PIC assembly.
Pugh BF
Mol Cell; 2006 Sep; 23(6):776-7. PubMed ID: 16973430
[TBL] [Abstract][Full Text] [Related]
9. Histone acetyltransferase activity of p300 enhances the activation of IL-18 promoter.
Sun H; Lu J; Xu X; Jin S; Wang X; Wei L; Dong M; Huang B
J Cell Biochem; 2005 Feb; 94(3):566-72. PubMed ID: 15543578
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity.
Gómez-Gonzalo M; Benedicto I; Carretero M; Lara-Pezzi E; Maldonado-Rodríguez A; Moreno-Otero R; Lai MM; López-Cabrera M
Virology; 2004 Oct; 328(1):120-30. PubMed ID: 15380363
[TBL] [Abstract][Full Text] [Related]
11. CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.
Kim JH; Cho EJ; Kim ST; Youn HD
Nat Struct Mol Biol; 2005 May; 12(5):423-8. PubMed ID: 15834423
[TBL] [Abstract][Full Text] [Related]
12. CBP/p300 histone acetyl-transferase activity is important for the G1/S transition.
Ait-Si-Ali S; Polesskaya A; Filleur S; Ferreira R; Duquet A; Robin P; Vervish A; Trouche D; Cabon F; Harel-Bellan A
Oncogene; 2000 May; 19(20):2430-7. PubMed ID: 10828885
[TBL] [Abstract][Full Text] [Related]
13. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
14. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
[TBL] [Abstract][Full Text] [Related]
15. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP.
Janknecht R; Nordheim A
Biochem Biophys Res Commun; 1996 Nov; 228(3):831-7. PubMed ID: 8941362
[TBL] [Abstract][Full Text] [Related]
16. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
Peterson LF; Lo MC; Okumura AJ; Zhang DE
Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
[TBL] [Abstract][Full Text] [Related]
17. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
18. Role of plant CBP/p300-like genes in the regulation of flowering time.
Han SK; Song JD; Noh YS; Noh B
Plant J; 2007 Jan; 49(1):103-14. PubMed ID: 17144897
[TBL] [Abstract][Full Text] [Related]
19. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.
Isono K; Nemoto K; Li Y; Takada Y; Suzuki R; Katsuki M; Nakagawara A; Koseki H
Mol Cell Biol; 2006 Apr; 26(7):2758-71. PubMed ID: 16537918
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.
Li XL; Arai Y; Harada H; Shima Y; Yoshida H; Rokudai S; Aikawa Y; Kimura A; Kitabayashi I
Oncogene; 2007 Nov; 26(51):7231-9. PubMed ID: 17533375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
